U.S. Product List

Committed to better health for individuals, Takeda in the U.S. markets innovative pharmaceutical treatments. To learn more about our oncology products, visit www.takedaoncology.com. Click on the product links for more detailed information on our other U.S. marketed products.

In addition to our on-the-market products, Takeda invests in an active R&D pipeline in an effort to bring new treatments to patients in need. Click here for more information on our global R&D pipeline.

Alphabetical by Brand Name

A B C D E F G H I K L M N O P R T U V

 

A

ACTOplus met (pioglitazone and metformin HCl)

ACTOplus met XR (Discontinued) [pioglitazone and metformin HCl (extended release)]

ADDERALL XR® (mixed salts of a single-entity amphetamine)

ADVATE® [Antihemophilic Factor (Recombinant)]

ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated]

AGRYLIN® (anagrelide hydrochloride)

PI

AMITIZA (lubiprostone)

PI

ARALAST® NP [Alpha1-Proteinase Inhibitor (Human)]

PI

 

B

BUMINATE® 5% [Albumin (Human)], USP, 5% Solution

PI

BUMINATE® 25% [Albumin (Human)], USP, 25% Solution

PI

 

C

CARBATROL®(carbamazepine)

CEPROTIN® [Protein C Concentrate (Human)]

CINRYZE® (C1 Esterase Inhibitor [Human])

COLCRYS (colchicine, USP)

PI

CUVITRU® [Immune Globulin Subcutaneous (Human)], 20% Solution

 

D

DEXILANT  (dexlansoprazole)

Duetact (pioglitazone and glimepiride)

 

E

ELAPRASE® (idursulfase) injection

ENTYVIO (vedolizumab)

 

F

FEIBA® (anti-inhibitor coagulant complex)

FIRAZYR® (icatibant injection)

FLEXBUMIN® 5% [Albumin (Human)], USP, 5% Solution

PI

FLEXBUMIN® 25% [Albumin (Human)], USP, 25% Solution

PI

FOSRENOL® (lanthanum carbonate)

 

G

GAMMAGARD LIQUID® [Immune Globulin Infusion (Human)], 10% Solution

GAMMAGARD® S/D [Immune Globulin Intravenous (Human)], IgA less than 1 mcg/ml in a 5% solution

GATTEX® (teduglutide) for injection

GLASSIA® [Alpha1-Proteinase Inhibitor (Human)]

 

H

HEMOFIL M® [Antihemophilic Factor (Human), Method M, Monoclonal Purified]

PI

HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution

 

I

INTUNIV® (guanfacine)

 

K

KALBITOR® (ecallantide) injection

KAZANO (alogliptin and metformin HCl)

 

L

LIALDA® (mesalamine)

PI

 

M

MOTEGRITYTM (prucalopride)

MYDAYIS®(mixed salts of a single-entity amphetamine)

 

N

NATPARA® (parathyroid hormone) for injection

NESINA (alogliptin)

 

O

OBIZUR® (Antihemophilic Factor [Recombinant], Porcine Sequence)

PI

OSENI (alogliptin and pioglitazone)

 

P

PENTASA® (mesalamine)

PI

PREVACID PREVACID SOLUTAB (lansoprazole)

PREVPAC (lansoprazole// amoxicillin// clarithromycin)

PI

 

R

RECOMBINATE® [Antihemophilic Factor (Recombinant)]

RIXUBIS® [Coagulation Factor IX (Recombinant)]

ROZEREM (ramelteon)

 

T

TAKHZYRO® (lanadelumab-flyo) injection

 

V

VONVENDI® [von Willebrand factor (Recombinant)]

VPRIV® (velaglucerase alfa for injection)

PI

VYVANSE® (lisdexamfetamine dimesylate), cii

 

Unless otherwise indicated, product names listed are trademarks of Takeda Pharmaceutical Company Limited or its subsidiaries registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc. or its affiliates.

AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

GLASSIA is a trademark of Kamada Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc. or its affiliates.

LIALDA is a trademark of Nogra Pharma Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc. or its affiliates.

PENTASA is a trademark of Ferring B.V. Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc. or its affiliates.

PREVACID is a trademark registered with the U.S. Patent and Trademark Office and SoluTab is a trademark of Takeda Pharmaceuticals U.S.A., Inc. and used under license by Takeda Pharmaceuticals America, Inc.

RECOMBINATE is a trademark of Takeda Pharmaceutical Company Limited or its subsidiaries used under license by Takeda Pharmaceuticals America, Inc. or its affiliates.

TRINTELLIX is a trademark of H. Lundbeck A/S registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

ULORIC is a trademark of Teijin Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.